Q22.1

Congenital pulmonary valve stenosis

Congenital pulmonary valve stenosis (PVS) is a congenital heart defect characterized by the narrowing or obstruction of the pulmonary valve, which controls the flow of deoxygenated blood from the right ventricle into the pulmonary artery toward the lungs. This narrowing typically results from malformed, thickened, or fused valve leaflets. The resulting obstruction increases the workload on the right ventricle as it attempts to overcome the pressure gradient, leading to right ventricular hypertrophy. If the stenosis is severe and left untreated, it can lead to right-sided heart failure and reduced cardiac output. While many patients with mild stenosis remain asymptomatic throughout life, those with moderate to severe stenosis may require intervention, such as balloon valvuloplasty or surgical valvotomy.

Clinical Symptoms

  • Systolic ejection murmur heard at the upper left sternal border
  • Exertional dyspnea (shortness of breath during physical activity)
  • Fatigue
  • Chest pain (angina) due to right ventricular strain
  • Syncope (fainting) or near-syncope
  • Cyanosis (bluish tint to skin, particularly in infants with critical stenosis)
  • Poor weight gain or failure to thrive in infants
  • Palpitations
  • Right ventricular heave
  • Peripheral edema in cases of advanced heart failure

Common Causes

  • Isolated idiopathic developmental defect during embryonic heart formation
  • Noonan syndrome (strongly associated genetic condition)
  • Alagille syndrome
  • Williams syndrome
  • Congenital rubella syndrome (maternal infection during pregnancy)
  • Maternal diabetes mellitus
  • Component of complex heart defects like Tetralogy of Fallot
  • Trisomy 13 (Patau syndrome)
  • Trisomy 18 (Edwards syndrome)

Documentation & Coding Tips

Explicitly define the hemodynamic severity of the pulmonary stenosis using peak systolic pressure gradients.

Example: Patient presents with severe congenital pulmonary valve stenosis, ICD-10-CM Q22.1. Transthoracic echocardiography reveals a peak systolic gradient of 75 mmHg across the pulmonary valve with significant right ventricular pressure overload. This chronic congenital condition is currently being managed with high-dose diuretics to address associated right-sided heart failure symptoms, impacting the complexity of medical decision-making for risk adjustment.

Billing Focus: The documentation of the peak gradient (e.g., over 60 mmHg) supports the medical necessity for high-intensity procedures and supports the clinical validity of the diagnosis code.

Distinguish between valvular, subvalvular, and supravalvular stenosis as they map to different ICD-10 codes.

Example: Clinical evaluation confirms congenital pulmonary valve stenosis (Q22.1) at the valvular level with thickened, doming leaflets. This is distinct from subvalvular infundibular stenosis (Q24.3) or supravalvular pulmonary artery stenosis (Q25.6), which are not present in this patient. The anatomical specificity is required for accurate 2026 coding standards and surgical planning.

Billing Focus: Site-specific documentation prevents the use of unspecified codes and ensures the diagnosis matches the procedural code for pulmonary valvuloplasty.

Document the presence or absence of secondary right ventricular hypertrophy.

Example: Diagnosis of congenital pulmonary valve stenosis (Q22.1) is complicated by the development of secondary right ventricular hypertrophy and associated tricuspid regurgitation. Current status is chronic, necessitating longitudinal monitoring of right-sided pressures. This comorbidity increases the patient's risk profile and justifies higher-level E/M services such as 99214.

Billing Focus: The presence of secondary manifestations like hypertrophy supports higher-level MDM and justifies the necessity for comprehensive cardiac imaging.

Note any history of surgical or interventional repairs and the current functional status of the repair.

Example: Patient has a history of neonatal balloon pulmonary valvuloplasty for congenital pulmonary valve stenosis (Q22.1). Current assessment shows residual mild stenosis with no evidence of restenosis or significant pulmonary insufficiency. The patient remains stable on current medical therapy for heart failure, which is maintained to prevent right ventricular remodeling.

Billing Focus: Distinguishing between a primary diagnosis and a post-procedural state ensures correct sequencing and use of Z-codes if the condition is resolved.

Quantify the impact of the stenosis on the patient's exercise tolerance and functional class.

Example: Congenital pulmonary valve stenosis (Q22.1) has progressed to causing New York Heart Association (NYHA) Class III symptoms, including marked limitation in physical activity and dyspnea on minimal exertion. The patient's functional decline necessitates a review of surgical intervention options. This status represents a high-risk chronic condition with severe systemic impact.

Billing Focus: Documenting functional class supports the medical necessity of surgical intervention (e.g., CPT 33475) and higher-level E/M codes.

Relevant CPT Codes

Related Diagnoses

Hierarchy